Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

  • This share is currently suspended. It was suspended at a price of 2.45
  • There is currently no data for AGFX

Form 8 (OPD) (Argentex Group PLC)

7 May 2025 13:15

RNS Number : 7200H
Argentex Group PLC
07 May 2025
 

FORM 8 (OPD)

 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Argentex Group PLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Argentex Group PLC

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

6 May 2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

 

Class of relevant security:

 

Ordinary shares of £0.0001 each

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

NIL

0.00

NIL

0.00

(2) Cash-settled derivatives:

 

NIL

0.00

NIL

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

NIL

0.00

NIL

0.00

 

TOTAL:

NIL

0.00

NIL

0.00

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

(b) Rights to subscribe for new securities

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

(A) The directors of the Offeree (and their close relatives and the related trusts of any of them) have interests in Ordinary Shares in the Offeree as follows:

 

Name

No. Ordinary Shares held

% of issued ordinary share capital

Nigel Railton

1,704,137*

1.41

Tim Rudman

8,766

0.00

Jonathan Gray

100,000

0.08

Tim Haldenby

54,716

0.04

*Inclusive of 274,615 Ordinary Shares held beneficially by his wife, Elizabeth Railton.

 

(B) The following director of the Offeree has an award granted under the Argentex 2025 Senior Executive Long Term Incentive Plan (the "Argentex 2025 LTIP") as follows:

 

Name

Type of award

No. growth A shares of £0.0001 each in the capital of Argentex Capital Limited* held

Grant date

Grant price

Vesting date

Tim Rudman

Growth shares**

1,040

3 April 2025

£55.38 per share

The end of a specified period following publication of the audited results of the Offeree for the financial year ending 31 December 2028.

*A wholly owned subsidiary of the Offeree.

*\* The growth shares are exchangeable for Ordinary Shares on the basis set out in the articles of association of Argentex Capital Limited subject to the Ordinary Shares having a value in excess of 65 pence per Ordinary Share on the vesting date or, if earlier, on the date of a change of control of the Offeree. Should the proposed acquisition of the Offeree by IFX (UK) Ltd (trading as IFX Payments) complete, this performance condition will remain unsatisfied and the growth shares will be acquired by the Offeree for nil consideration and (at the Offeree's option) will convert into deferred shares in the capital of Argentex Capital Limited (on a 1:1 basis).

 

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None.

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None.

 

(c) Attachments

 

Are any Supplemental Forms attached?

 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

 

 

Date of disclosure:

7 May 2025

Contact name:

Alethia McDonald

Telephone number:

+44 (0) 20 3862 1604

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEEUBUARVBUVRAR
Date   Source Headline
2nd Sep 20257:00 amRNSCancellation - Argentex Group PLC
7th Aug 20257:09 amRNSTermination of recommended cash acquisition by IFX
7th Aug 20257:00 amRNSLapsing of Acquisition
1st Aug 20259:37 amRNSResignation of Nominated Adviser and Broker
24th Jul 20253:29 pmRNSAppointment of Administrators
22nd Jul 20258:54 amRNSBoard change
21st Jul 20256:00 pmRNSAppointment of Special Administrators
21st Jul 20257:00 amRNSStatement re recommended acquisition of Argentex
18th Jul 20254:30 pmRNSIntention to Appoint Administrators
18th Jul 20257:00 amRNSAnnouncement of VREQ
17th Jul 20259:46 amRNSForm 8.5 (EPT/RI)
17th Jul 20257:30 amRNSSuspension - Argentex Group plc
17th Jul 20257:00 amRNSUpdate on Financial Position and Suspension
16th Jul 202510:41 amRNSForm 8.5 (EPT/RI)
15th Jul 202511:12 amRNSForm 8.5 (EPT/RI)
15th Jul 20258:57 amRNSForm 8 (DD) - IFX (UK) Ltd
14th Jul 202511:51 amRNSForm 8.5 (EPT/RI)
14th Jul 202510:24 amRNSForm 8 (DD) - IFX (UK) Ltd
11th Jul 202512:01 pmRNSForm 8.5 (EPT/RI)
10th Jul 202510:55 amRNSForm 8.5 (EPT/RI)
9th Jul 20259:48 amRNSForm 8.5 (EPT/RI)
9th Jul 20258:12 amRNSForm 8 (DD) - Argentex Group PLC
8th Jul 202510:47 amRNSForm 8.5 (EPT/RI)
8th Jul 20258:48 amRNSForm 8 (DD) - IFX (UK) Ltd
8th Jul 20257:00 amRNSAmendment to RCF & Announcement of VREQ
4th Jul 202510:04 amRNSForm 8.5 (EPT/RI)
3rd Jul 202512:11 pmRNSForm 8.5 (EPT/RI)
2nd Jul 202512:07 pmRNSForm 8.5 (EPT/RI)
1st Jul 202511:16 amRNSForm 8.5 (EPT/RI)
30th Jun 20254:43 pmRNSForm 8 (DD) - IFX (UK) Ltd - AMEND
30th Jun 202511:35 amRNSForm 8.5 (EPT/RI)
30th Jun 20259:48 amRNSForm 8 (DD) - IFX (UK) Ltd
27th Jun 202510:33 amRNSForm 8 (DD) - Argentex Group PLC
27th Jun 202510:03 amRNSForm 8.5 (EPT/RI)
26th Jun 202512:00 pmRNSAnnouncement of VREQ
26th Jun 202511:57 amRNSForm 8.5 (EPT/RI)
26th Jun 20259:13 amRNSForm 8 (DD) - Argentex Group PLC
25th Jun 202510:09 amRNSForm 8.5 (EPT/RI)
25th Jun 202510:08 amRNSForm 8 (DD) - Argentex Group PLC
24th Jun 202510:01 amRNSForm 8.5 (EPT/RI) Argentex Group PLC
23rd Jun 202510:33 amRNSForm 8 (DD) - Argentex Group PLC
23rd Jun 202510:12 amRNSForm 8.5 (EPT/RI)
20th Jun 202511:13 amRNSForm 8 (DD) - Argentex Group PLC
20th Jun 202510:09 amRNSForm 8.5 (EPT/RI)
19th Jun 202512:02 pmRNSForm 8.5 (EPT/RI)
18th Jun 202512:02 pmRNSForm 8.5 (EPT/RI)
17th Jun 20259:52 amRNSForm 8.5 (EPT/RI)
16th Jun 20259:19 amRNSForm 8.5 (EPT/RI)
13th Jun 202512:06 pmRNSForm 8.5 (EPT/RI)
12th Jun 202511:57 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.